312 related articles for article (PubMed ID: 14648068)
21. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells.
Finberg RW; White W; Nicholson-Weller A
J Immunol; 1992 Sep; 149(6):2055-60. PubMed ID: 1381394
[TBL] [Abstract][Full Text] [Related]
22. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity.
Paya CV; Kenmotsu N; Schoon RA; Leibson PJ
J Immunol; 1988 Sep; 141(6):1989-95. PubMed ID: 2844893
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
Shau HY; Golub SH
J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
26. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
27. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M
Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
[TBL] [Abstract][Full Text] [Related]
29. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells.
Velthuis JH; de Bont HJ; Medema JP; Kuppen PJ; Mulder GJ; Nagelkerke JF
Immunobiology; 2003; 207(2):115-27. PubMed ID: 12675269
[TBL] [Abstract][Full Text] [Related]
31. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
Yanovich S; Hall RE; Weinert C
Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
[TBL] [Abstract][Full Text] [Related]
32. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
33. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.
Schempp CM; Simon-Haarhaus B; Termeer CC; Simon JC
FEBS Lett; 2001 Mar; 493(1):26-30. PubMed ID: 11277999
[TBL] [Abstract][Full Text] [Related]
34. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity.
Ohuchida T; Okamoto K; Akahane K; Higure A; Todoroki H; Abe Y; Kikuchi M; Ikematsu S; Muramatsu T; Itoh H
Cancer; 2004 Jun; 100(11):2430-6. PubMed ID: 15160348
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
36. Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells.
Alarcón B; Fresno M
J Immunol; 1985 Feb; 134(2):1286-91. PubMed ID: 2981268
[TBL] [Abstract][Full Text] [Related]
37. Anti-cancer activity and mechanistic features of a NK cell activating molecule.
Kim HR; Lee KH; Park SJ; Kim SY; Yang YK; Tae J; Kim J
Cancer Immunol Immunother; 2009 Oct; 58(10):1691-700. PubMed ID: 19259669
[TBL] [Abstract][Full Text] [Related]
38. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis.
Matsui H; Hikichi Y; Tsuji I; Yamada T; Shintani Y
J Biol Chem; 2002 Dec; 277(51):50054-61. PubMed ID: 12393901
[TBL] [Abstract][Full Text] [Related]
39. Intra- and interspecies reactivity of human and mouse natural killer (NK) cells.
Hansson M; Bakacs KK; Kiessling R; Klein G
J Immunol; 1978 Jul; 121(1):6-12. PubMed ID: 78947
[TBL] [Abstract][Full Text] [Related]
40. Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells.
Hasegawa Y; Bonavida B
J Immunol; 1989 Apr; 142(8):2670-6. PubMed ID: 2495322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
